ATE476450T1 - Vernetzte polysaccharidzusammensetzung - Google Patents

Vernetzte polysaccharidzusammensetzung

Info

Publication number: ATE476450T1
Authority: AT; Austria
Prior art keywords: cross; linked polysaccharide; polysaccharide composition; gels; linked
Prior art date: 2003-04-17

Application number

AT04727786T

Other languages

English (en)

Inventor

Simone Vonwiller

Geoffrey Heber

Original Assignee

Ultraceuticals R & D Pty Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-17

Filing date

2004-04-16

Publication date

2010-08-15

2004-04-16 Application filed by Ultraceuticals R & D Pty Ltd filed Critical Ultraceuticals R & D Pty Ltd

2010-08-15 Application granted granted Critical

2010-08-15 Publication of ATE476450T1 publication Critical patent/ATE476450T1/de

Links

150000004676 glycans Chemical class 0.000 title abstract 2
229920001282 polysaccharide Polymers 0.000 title abstract 2
239000005017 polysaccharide Substances 0.000 title abstract 2
239000000499 gel Substances 0.000 abstract 3
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
230000015556 catabolic process Effects 0.000 abstract 1
239000002537 cosmetic Substances 0.000 abstract 1
238000006731 degradation reaction Methods 0.000 abstract 1
229920002674 hyaluronan Polymers 0.000 abstract 1
229960003160 hyaluronic acid Drugs 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/738—Cross-linked polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Materials Engineering (AREA)
Polymers & Plastics (AREA)
Biochemistry (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Inorganic Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Transplantation (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)

AT04727786T 2003-04-17 2004-04-16 Vernetzte polysaccharidzusammensetzung ATE476450T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AU2003901834A AU2003901834A0 (en)	2003-04-17	2003-04-17	Cross-linked polysaccharide compositions
PCT/AU2004/000509 WO2004092223A1 (en)	2003-04-17	2004-04-16	Cross-linked polysaccharide composition

Publications (1)

Publication Number	Publication Date
ATE476450T1 true ATE476450T1 (de)	2010-08-15

Family

ID=31500871

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04727786T ATE476450T1 (de)	2003-04-17	2004-04-16	Vernetzte polysaccharidzusammensetzung

Country Status (13)

Country	Link
US (2)	US20070026070A1 (de)
EP (1)	EP1613663B1 (de)
JP (2)	JP2006523731A (de)
KR (1)	KR20060008906A (de)
CN (1)	CN100509858C (de)
AT (1)	ATE476450T1 (de)
AU (1)	AU2003901834A0 (de)
BR (1)	BRPI0409890A (de)
CA (1)	CA2522232C (de)
DE (1)	DE602004028455D1 (de)
ES (1)	ES2349924T3 (de)
MX (1)	MXPA05011098A (de)
WO (1)	WO2004092223A1 (de)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7090745B2 (en) *	2002-09-13	2006-08-15	University Of Pittsburgh	Method for increasing the strength of a cellulosic product
FR2861734B1 (fr)	2003-04-10	2006-04-14	Corneal Ind	Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
AU2003901834A0 (en) *	2003-04-17	2003-05-01	Clearcoll Pty Ltd	Cross-linked polysaccharide compositions
US7846693B2 (en)	2003-09-04	2010-12-07	Human Genetic Signatures Pty. Ltd.	Nucleic acid detection assay
US8168777B2 (en)	2004-04-29	2012-05-01	Human Genetic Signatures Pty. Ltd.	Bisulphite reagent treatment of nucleic acid
US20050281880A1 (en) *	2004-05-20	2005-12-22	Wei Wang	Methods for making injectable polymer hydrogels
EP1794173B1 (de) *	2004-09-10	2010-08-04	Human Genetic Signatures PTY Ltd	Amplifikationsblocker umfassend interkalierende nukleinsäuren (ina) enthaltend interkalierende pseudonukleotide (ipn)
US7833942B2 (en) *	2004-12-03	2010-11-16	Human Genetic Signatures Pty. Ltd.	Methods for simplifying microbial nucleic acids by chemical modification of cytosines
CA2609218C (en)	2005-05-26	2016-10-11	Human Genetic Signatures Pty Ltd	Isothermal strand displacement amplification using primers containing a non-regular base
US8343738B2 (en) *	2005-09-14	2013-01-01	Human Genetic Signatures Pty. Ltd.	Assay for screening for potential cervical cancer
EP1928918B1 (de) *	2005-09-27	2011-11-16	UNIVERSITE JOSEPH FOURIER - Grenoble 1	Mit einer polymerisierbaren gruppierung funktionalisiertes hydrogel und anwendungen davon als biosensoren oder bioreaktoren
US20080050738A1 (en) *	2006-05-31	2008-02-28	Human Genetic Signatures Pty Ltd.	Detection of target nucleic acid
US20100035838A1 (en) *	2006-09-19	2010-02-11	Geoffrey Kenneth Heber	Cross-linked polysaccharide gels
FR2909560B1 (fr) *	2006-12-06	2012-12-28	Fabre Pierre Dermo Cosmetique	Gel d'acide hyaluronique pour injection intradermique
AU2008229628A1 (en) *	2007-03-16	2008-09-25	Human Genetic Signatures Pty Ltd	Assay for gene expression
JP2008255061A (ja) *	2007-04-06	2008-10-23	Shiseido Co Ltd	可溶性架橋ヒアルロン酸含有眼用組成物
WO2008147867A2 (en) *	2007-05-23	2008-12-04	Allergan, Inc.	Cross-linked collagen and uses thereof
US20110077737A1 (en) *	2007-07-30	2011-03-31	Allergan, Inc.	Tunably Crosslinked Polysaccharide Compositions
US8318695B2 (en) *	2007-07-30	2012-11-27	Allergan, Inc.	Tunably crosslinked polysaccharide compositions
US20120071437A1 (en) *	2007-07-30	2012-03-22	Allergan, Inc.	Tunable crosslinked polysaccharide compositions
ES2381417T3 (es) *	2007-09-28	2012-05-28	Shiseido Company, Ltd.	Polvo de ácido hialurónico reticulado hinchable y procedimiento para fabricarlo
US9433805B2 (en) *	2007-10-04	2016-09-06	Ultraceuticals R&D Pty Ltd.	Method for dermal regeneration by administering an ether cross-linked glucomannan/hyaluronic acid composition
US8697044B2 (en)	2007-10-09	2014-04-15	Allergan, Inc.	Crossed-linked hyaluronic acid and collagen and uses thereof
US8114898B2 (en)	2007-11-16	2012-02-14	Allergan, Inc.	Compositions and methods for treating purpura
US8685675B2 (en)	2007-11-27	2014-04-01	Human Genetic Signatures Pty. Ltd.	Enzymes for amplification and copying bisulphite modified nucleic acids
US8394782B2 (en) *	2007-11-30	2013-03-12	Allergan, Inc.	Polysaccharide gel formulation having increased longevity
US8394784B2 (en) *	2007-11-30	2013-03-12	Allergan, Inc.	Polysaccharide gel formulation having multi-stage bioactive agent delivery
US20090143348A1 (en) *	2007-11-30	2009-06-04	Ahmet Tezel	Polysaccharide gel compositions and methods for sustained delivery of drugs
EP2222850A4 (de) *	2007-12-20	2011-12-07	Human Genetic Signatures Pty	Beseitigung von kontaminanten in zusammenhang mit nukleinsäureamplifikation
JP5718806B2 (ja) *	2008-03-27	2015-05-13	グリーン，ツイードオブデラウェア，インコーポレイテッド	不活性支持体に結合したフルオロエラストマー構成部品および関連する方法
KR101027630B1 (ko) *	2008-06-18	2011-04-07	주식회사 제네웰	연골 재생용 다공성 히알루론산-콜라겐 천연 고분자 지지체의 제조방법
US8357795B2 (en)	2008-08-04	2013-01-22	Allergan, Inc.	Hyaluronic acid-based gels including lidocaine
AU2009288118B2 (en)	2008-09-02	2014-12-11	Allergan, Inc.	Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
PT2236523T (pt)	2009-03-30	2018-03-21	Scivision Biotech Inc	Método para produzir ácido hialurónico reticulado
US9371402B2 (en)	2009-04-09	2016-06-21	Scivision Biotech Inc.	Method for producing cross-linked hyaluronic acid
CN101544705B (zh) *	2009-05-04	2011-09-14	西南大学	蔗糖缩水甘油醚交联剂、抗皱整理剂及其合成方法
US9265610B2 (en) *	2009-07-10	2016-02-23	Peter Forsell	Implantable medical device for lubrication of a synovial joint and method for implanting the device
US20110172180A1 (en)	2010-01-13	2011-07-14	Allergan Industrie. Sas	Heat stable hyaluronic acid compositions for dermatological use
US20110171310A1 (en) *	2010-01-13	2011-07-14	Allergan Industrie, Sas	Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
US20110171311A1 (en) *	2010-01-13	2011-07-14	Allergan Industrie, Sas	Stable hydrogel compositions including additives
US20110171286A1 (en) *	2010-01-13	2011-07-14	Allergan, Inc.	Hyaluronic acid compositions for dermatological use
US9114188B2 (en)	2010-01-13	2015-08-25	Allergan, Industrie, S.A.S.	Stable hydrogel compositions including additives
CN102905677A (zh)	2010-03-12	2013-01-30	阿勒根工业有限公司	用于改善皮肤状况的包含透明质烷聚合物和甘露糖醇的流体组合物
ES2585388T5 (es)	2010-03-22	2019-08-08	Allergan Inc	Hidrogeles reticulados de polisacárido y proteína-polisacárido para aumento de tejido blando
KR101734853B1 (ko) *	2010-06-08	2017-05-12	다우 글로벌 테크놀로지스 엘엘씨	가역적으로 가교결합된 미립 중합체성 물질의 제조방법
ITUD20100112A1 (it) *	2010-06-09	2011-12-10	Farma Derma S R L	Preparazione per uso vaginale e rettale e relativo procedimento di produzione
US8889123B2 (en)	2010-08-19	2014-11-18	Allergan, Inc.	Compositions and soft tissue replacement methods
US9005605B2 (en)	2010-08-19	2015-04-14	Allergan, Inc.	Compositions and soft tissue replacement methods
US8883139B2 (en)	2010-08-19	2014-11-11	Allergan Inc.	Compositions and soft tissue replacement methods
US8697057B2 (en)	2010-08-19	2014-04-15	Allergan, Inc.	Compositions and soft tissue replacement methods
US20130096081A1 (en)	2011-06-03	2013-04-18	Allergan, Inc.	Dermal filler compositions
US9408797B2 (en)	2011-06-03	2016-08-09	Allergan, Inc.	Dermal filler compositions for fine line treatment
US9393263B2 (en)	2011-06-03	2016-07-19	Allergan, Inc.	Dermal filler compositions including antioxidants
KR102312056B1 (ko)	2011-06-03	2021-10-12	알러간 인더스트리 에스에이에스	항산화제를 포함하는 피부 충전제 조성물
US20130244943A1 (en)	2011-09-06	2013-09-19	Allergan, Inc.	Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
US9662422B2 (en)	2011-09-06	2017-05-30	Allergan, Inc.	Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
EP2753710B1 (de)	2011-09-07	2017-01-11	Human Genetic Signatures Pty Ltd	Molekularer detektionstest
KR101428145B1 (ko) *	2011-11-24	2014-08-08	(주)아모레퍼시픽	수불용성 겔 조성물 및 그 제조방법
KR101240518B1 (ko) *	2012-03-26	2013-03-11	주식회사 제네웰	생체 적합성 고분자를 이용한 이식용 재료
ITMI20120732A1 (it)	2012-05-03	2013-11-04	B S Srl	Polisaccaridi reticolati a memoria di forma
KR101413510B1 (ko) *	2012-06-19	2014-07-02	주식회사 제네웰	생체 적합성 고분자를 이용한 이식용 재료의 제조방법
SG10201701773UA (en) *	2012-09-06	2017-04-27	Univ Nanyang Tech	Hyaluronic Acid-Based Drug Delivery Systems
FR3005056B1 (fr) *	2013-04-24	2016-04-01	Ayawane	Hydrogel a base de polysaccharides natifs et/ou fonctionnalises, phosphates co-reticules
BR112015031457A2 (pt) *	2013-06-28	2017-07-25	Galderma Sa	processo para preparar um produto do ácido hialurônico reticulado
AU2015206504B2 (en) *	2014-01-17	2018-08-16	E. I. Du Pont De Nemours And Company	Production of a solution of cross-linked poly alpha-1,3-glucan and poly alpha-1,3-glucan film made therefrom
WO2016051219A1 (en)	2014-09-30	2016-04-07	Allergan Industrie, Sas	Stable hydrogel compositions including additives
CN104387609B (zh) *	2014-11-18	2018-06-01	中国林业科学研究院林产化学工业研究所	一种纤维素多孔吸附材料的制备方法
WO2016128783A1 (en)	2015-02-09	2016-08-18	Allergan Industrie Sas	Compositions and methods for improving skin appearance
PL3256179T3 (pl)	2015-02-13	2020-05-18	Allergan Industrie, Sas	Implanty do kształtowania, uwydatniania lub korygowania cech twarzy takich jak broda
FR3032617B1 (fr) *	2015-02-16	2018-03-16	Kylane Laboratoires Sa	Procede de preparation d un hydrogel injectable; hydrogel obtenu; utilisation de l hydrogel obtenu
CN104721873B (zh) *	2015-03-12	2016-06-29	北京蒙博润生物科技有限公司	片状交联透明质酸钠水凝胶的制备
EP3375456B1 (de)	2015-11-12	2023-05-03	Terumo Kabushiki Kaisha	Topisch verabreichtes mittel mit verzögerter freisetzung
CN105504316B (zh) *	2016-01-29	2017-12-29	清华大学	一种透明质酸‑甲基纤维素复合凝胶的活性酯交联方法
CN107998437B (zh) *	2016-10-31	2021-07-13	常州药物研究所有限公司	纳米交联透明质酸钠凝胶及其制备方法和应用
AR111190A1 (es)	2017-03-22	2019-06-12	Genentech Inc	Composiciones en hidrogel de prodrogas entrecruzadas de ácido hialurónico y métodos relacionados
CN108047351A (zh) *	2017-12-15	2018-05-18	浙江景嘉医疗科技有限公司	一种低交联度透明质酸钠的制备方法
EP3787702B1 (de)	2018-05-03	2024-08-07	CollPlant Ltd.	Dermale füllstoffe und deren anwendungen
CN109531857B (zh) *	2019-01-02	2020-11-06	华熙生物科技股份有限公司	一种透明质酸或其盐颗粒的制备方法及所得产品
CN110038161B (zh) *	2019-04-29	2021-07-30	上海交通大学	一种新型透明质酸流动凝胶及其制备方法和应用
CN113061265A (zh) *	2021-02-18	2021-07-02	中国人民解放军空军军医大学	一种多糖类水凝胶，其制备方法及其应用
CN113413484B (zh) *	2021-06-21	2023-02-10	浙江苏嘉医疗器械股份有限公司	可用于人体软组织填充的植入材料
KR102640893B1 (ko) *	2021-11-12	2024-02-27	주식회사 유영제약	히알루론산 가교물을 포함하는 조성물의 제조방법
CN115246889B (zh) *	2022-09-23	2023-01-10	常熟威怡科技有限公司	一种羧甲基纤维素锂及其制备方法和应用
CN117064067A (zh) *	2023-08-07	2023-11-17	湖北工业大学	一种具有可控酵解速率的膳食纤维及其制备方法与应用
CN120025572B (zh) *	2025-04-21	2025-07-25	上海惠盾因泰生物科技有限公司	一种具有抗酶解性能的葡聚糖-透明质酸钠凝胶的制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2553099B1 (fr)	1983-10-11	1989-09-08	Fidia Spa	Fractions d'acide hyaluronique ayant une activite pharmaceutique, procedes pour leur preparation et compositions pharmaceutiques les contenant
CA1238043A (en) *	1983-12-15	1988-06-14	Endre A. Balazs	Water insoluble preparations of hyaluronic acid and processes therefor
JPS60166301A (ja) *	1984-02-10	1985-08-29	Okura Ind Co Ltd	セルロ−ス系材料成形品の製造方法
US4582865A (en) *	1984-12-06	1986-04-15	Biomatrix, Inc.	Cross-linked gels of hyaluronic acid and products containing such gels
SE8501022L (sv) *	1985-03-01	1986-09-02	Pharmacia Ab	Format alster och forfarande for dess framstellning
SE452469B (sv) *	1986-06-18	1987-11-30	Pharmacia Ab	Material bestaende av en tverbunden karboxylgrupphaltig polysackarid och forfarande vid framstellning av detsamma
DE3726454A1 (de) *	1987-08-08	1989-02-16	Behringwerke Ag	Thiolgruppenhaltige polymere, verfahren zu ihrer herstellung und ihre verwendung
IT1219587B (it) *	1988-05-13	1990-05-18	Fidia Farmaceutici	Polisaccaridi carbossiilici autoreticolati
GB9024223D0 (en) *	1990-11-07	1990-12-19	Fermentech Ltd	Production of hyaluronic acid
JPH05140201A (ja) *	1991-11-25	1993-06-08	Shiseido Co Ltd	架橋ヒアルロン酸ゲル及びその製造方法
JPH06102229A (ja) *	1992-09-18	1994-04-15	Daikin Ind Ltd	半透性膜およびその製造方法
EP0628284B1 (de) *	1992-12-02	2001-06-06	Shiseido Company Limited	Koppelmittel für eine ultraschall-sonde
FR2717815A1 (fr) *	1994-03-25	1995-09-29	Gel Sciences Inc	Nouveaux polymères gélifiables à base d'acide hyaluronique et leur procédé de préparation.
US5690961A (en) *	1994-12-22	1997-11-25	Hercules Incorporated	Acidic polysaccharides crosslinked with polycarboxylic acids and their uses
US5827937A (en) *	1995-07-17	1998-10-27	Q Med Ab	Polysaccharide gel composition
GB9902412D0 (en) *	1999-02-03	1999-03-24	Fermentech Med Ltd	Process
NO314525B1 (no) *	1999-04-22	2003-03-31	Thin Film Electronics Asa	Fremgangsmåte ved fremstillingen av organiske halvledende innretninger i tynnfilm
FR2811996B1 (fr) *	2000-07-19	2003-08-08	Corneal Ind	Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations
CA2351253A1 (en) *	2000-11-10	2002-05-10	Groupe Lysac Inc./Lysac Group Inc.	Crosslinked polysaccharide, obtained by crosslinking with substituted polyethylene glycol, as superabsorbent
TW574301B (en) *	2001-05-02	2004-02-01	Ind Tech Res Inst	Manufacturing method of epoxide crosslinked polysaccharides matrix
AU2003901834A0 (en) *	2003-04-17	2003-05-01	Clearcoll Pty Ltd	Cross-linked polysaccharide compositions

2003
- 2003-04-17 AU AU2003901834A patent/AU2003901834A0/en not_active Abandoned
2004
- 2004-04-16 CN CNB2004800102391A patent/CN100509858C/zh not_active Expired - Fee Related
- 2004-04-16 CA CA002522232A patent/CA2522232C/en not_active Expired - Fee Related
- 2004-04-16 KR KR1020057019805A patent/KR20060008906A/ko not_active Ceased
- 2004-04-16 AT AT04727786T patent/ATE476450T1/de not_active IP Right Cessation
- 2004-04-16 DE DE602004028455T patent/DE602004028455D1/de not_active Expired - Lifetime
- 2004-04-16 EP EP04727786A patent/EP1613663B1/de not_active Expired - Lifetime
- 2004-04-16 US US10/552,881 patent/US20070026070A1/en not_active Abandoned
- 2004-04-16 JP JP2006504014A patent/JP2006523731A/ja active Pending
- 2004-04-16 ES ES04727786T patent/ES2349924T3/es not_active Expired - Lifetime
- 2004-04-16 MX MXPA05011098A patent/MXPA05011098A/es active IP Right Grant
- 2004-04-16 WO PCT/AU2004/000509 patent/WO2004092223A1/en not_active Ceased
- 2004-04-16 BR BRPI0409890-0A patent/BRPI0409890A/pt not_active IP Right Cessation
2007
- 2007-12-28 JP JP2007339384A patent/JP2008133474A/ja active Pending
2013
- 2013-12-26 US US14/141,018 patent/US8877243B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US8877243B2 (en)	2014-11-04
EP1613663A4 (de)	2006-10-11
JP2006523731A (ja)	2006-10-19
EP1613663B1 (de)	2010-08-04
CA2522232C (en)	2007-07-03
WO2004092223A1 (en)	2004-10-28
MXPA05011098A (es)	2005-12-15
JP2008133474A (ja)	2008-06-12
DE602004028455D1 (de)	2010-09-16
CA2522232A1 (en)	2004-10-28
US20140105852A1 (en)	2014-04-17
KR20060008906A (ko)	2006-01-27
ES2349924T3 (es)	2011-01-13
US20070026070A1 (en)	2007-02-01
AU2003901834A0 (en)	2003-05-01
CN100509858C (zh)	2009-07-08
EP1613663A1 (de)	2006-01-11
BRPI0409890A (pt)	2006-05-23
CN1774450A (zh)	2006-05-17

Legal Events

Date	Code	Title	Description
2011-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE476450T1 (de)	2010-08-15	Vernetzte polysaccharidzusammensetzung
ATE552864T1 (de)	2012-04-15	Therapeutisch aktive wundauflagen, deren herstellung und deren verwendung
DK1443945T3 (da)	2009-01-12	Anvendelse af en blanding af natriumhyaluronat og chondroitinsulfat til behandling af slidgigt eller chondromalacia
ES2367583T5 (es)	2011-11-04	Hidrogeles con enlaces de hidrogeno.
PT910412E (pt)	2003-09-30	Hidrogeis hidrolisaveis para libertacao controlada
PT1411908E (pt)	2005-08-31	Tratamento de infeccoes da unha com no
WO2004078120A3 (en)	2005-09-22	Collagen compositions and biomaterials
DE50306232D1 (de)	2007-02-15	Ampholytisches copolymer und dessen verwendung
DE60113121T2 (de)	2006-06-14	Herstellung von vernetzter Hyaluronsäure und dessen Hydrogel, daraus hergestellte Produkte und deren Verwendung
BRPI0413728A (pt)	2006-10-24	muteìnas de lipocalina da lágrima
BR0215888A (pt)	2005-07-26	Goma de mascar compreendendo pelo menos dois diferentes polìmeros biodegradáveis
ATE302235T1 (de)	2005-09-15	Gel aus einem poly-a-1,4-glucan und stärke
DK1644348T3 (da)	2007-10-22	Epoxy-afsluttede polythioethere, Epoxy-afsluttede polythioethere
EP1670450A4 (de)	2008-08-27	Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
CY1105748T1 (el)	2010-12-22	Χρηση της ριλουζολης συνδυασμενης με καταλληλα εκδοχα και προσθετες ουσιες για τη θεραπεια ασθενειων που χαρακτηριζονται απο υπερβολικο πολλαπλασιασμο των κερατινοκυτταρων ιδιαιτερως της νευροδερματιτιδας και της ψωριασης
WO2002100437A3 (en)	2003-04-24	Ophthalmic compositions comprising hyaluronic acid
ATE497489T1 (de)	2011-02-15	Nichtsymmetrisches geliermittel
ATE396744T1 (de)	2008-06-15	Netzwerk auf polysaccharidbasis und verfahren zu dessen herstellung
BR0308486A (pt)	2005-01-18	Composição tópica compreendendo um ciclofrutano, um veìculo e uma droga
WO2010078036A3 (en)	2010-10-28	Biocompatible polysaccharide-based hydrogels
AU2003255621A1 (en)	2003-12-19	Topical use of at least one double-stranded rna oligonucleotide (ds rna)
BR0307518A (pt)	2004-12-28	Composição farmacêutica
BRPI0413446A (pt)	2006-10-17	gel bioadesivo á base de hidroxietilcelulose
TW200510012A (en)	2005-03-16	Aqua gel comprising temperature effect
TW200517144A (en)	2005-06-01	Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties